BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 29, 2005
View Archived Issues
Second closing of Cellerant Therapeutics' Series B financing
Read More
NAP and ADNF-9 exert neuroprotective effects via PARP-1 activation and polyADP-ribosylation
Read More
IFN-alpha-XL shows promise in the management of chronic hepatitis C
Read More
First data on the antitumor efficacy of artesunate in metastatic uveal melanoma
Read More
Cubist submits Cubicin sNDA filing, requests priority review
Read More
Glenmark seeks clearance for phase I trials of DPP-IV inhibitor GRC-8200
Read More
International Medical Innovations changes name to PreMD
Read More
Revised reporting date for phase III study of Corlux
Read More
Corcept closes enrollment in Corlux study in Alzheimer's patients
Read More
Low dose oral interferon alpha studied for bone marrow proliferative disorders
Read More
ADX-10059 enters phase I studies for anxiety disorders and migraine
Read More
VT-111 begins phase II trial for acute coronary syndromes
Read More
Actilon begins phase Ib study for chronic HCV
Read More
AT-1001 enters phase I testing for celiac disease
Read More
Tissue distribution of SVT-40776 indicates a good safety profile
Read More
Pentacel BLA accepted for filing
Read More
UR-1505 modulates T cell proliferation and cytokine production
Read More
New data presented on GSK-3 dual inhibitor that demonstrates bone formation
Read More
Lck inhibition prevents acute rejection of heart transplants
Read More
Regeneron updates progress of key programs
Read More
Exatecan mesilate investigated in metastatic gastric cancer
Read More
Approvable letter for iPlex
Read More
Positive opinions in Europe for Combigan
Read More
Studies reveal temsirolimus activity in different cancers
Read More
Stiefel licenses albaconazole from Uriach
Read More
Recent patents report novel treatments for obesity
Read More
DOV-216303 shows promise in the management of major depression
Read More
Phase I data on arsenic trioxide plus dacarbazine in metastatic melanoma
Read More
Canvaxin improves survival of patients with high-risk melanoma
Read More
New thrombin inhibitors claimed in AstraZeneca patent
Read More
BAY-43-9006 shows antitumor activity in metastatic melanoma
Read More
Novel agents for diabetes and related complications reported in recent patent literature
Read More